AP645A - Benzamine derivative, compositions containing said derivative and use thereof. - Google Patents

Benzamine derivative, compositions containing said derivative and use thereof. Download PDF

Info

Publication number
AP645A
AP645A APAP/P/1996/000866A AP9600866A AP645A AP 645 A AP645 A AP 645A AP 9600866 A AP9600866 A AP 9600866A AP 645 A AP645 A AP 645A
Authority
AP
ARIPO
Prior art keywords
compound
formula
agent
symbol
remaining symbols
Prior art date
Application number
APAP/P/1996/000866A
Other languages
English (en)
Other versions
AP9600866A0 (en
Inventor
Jean-Francois Rossignol
Original Assignee
Romark Laboratories Lc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27397680&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP645(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/227,033 external-priority patent/US5387598A/en
Priority claimed from US08/301,407 external-priority patent/US5578621A/en
Application filed by Romark Laboratories Lc filed Critical Romark Laboratories Lc
Publication of AP9600866A0 publication Critical patent/AP9600866A0/xx
Application granted granted Critical
Publication of AP645A publication Critical patent/AP645A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/58—Nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
APAP/P/1996/000866A 1994-04-13 1995-04-11 Benzamine derivative, compositions containing said derivative and use thereof. AP645A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/227,033 US5387598A (en) 1994-04-13 1994-04-13 Composition and galenic formulation suitable for combatting affections of the lower abdomen
US08/301,407 US5578621A (en) 1994-09-08 1994-09-08 Benzamide derivatives
US38385595A 1995-02-06 1995-02-06
PCT/EP1995/001334 WO1995028393A1 (en) 1994-04-13 1995-04-11 Benzamide derivative, compositions containing said derivative and use thereof

Publications (2)

Publication Number Publication Date
AP9600866A0 AP9600866A0 (en) 1996-10-31
AP645A true AP645A (en) 1998-04-24

Family

ID=27397680

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1996/000866A AP645A (en) 1994-04-13 1995-04-11 Benzamine derivative, compositions containing said derivative and use thereof.

Country Status (24)

Country Link
EP (1) EP0755386B1 (da)
JP (1) JP3224395B2 (da)
KR (2) KR100348440B1 (da)
CN (1) CN1072654C (da)
AP (1) AP645A (da)
AT (1) ATE218557T1 (da)
AU (1) AU689582B2 (da)
BG (1) BG62932B1 (da)
BR (1) BR9507371A (da)
CA (1) CA2187110C (da)
CZ (1) CZ287002B6 (da)
DE (1) DE69526936T2 (da)
DK (1) DK0755386T3 (da)
ES (1) ES2161201T3 (da)
FI (1) FI120258B (da)
HU (1) HUT77404A (da)
NZ (1) NZ284800A (da)
OA (1) OA10463A (da)
PL (1) PL186504B1 (da)
PT (1) PT755386E (da)
RU (1) RU2140915C1 (da)
SI (1) SI0755386T1 (da)
SK (1) SK281949B6 (da)
WO (1) WO1995028393A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856348A (en) * 1994-09-08 1999-01-05 Romark Laboratories, L.C. Method for treatment of trematodes with pharmaceutical compositions of tizoxanide and nitazoxanide
US5968961A (en) 1997-05-07 1999-10-19 Romark Laboratories, L.C. Pharmaceutical compositions of tizoxanide and nitazoxanide
CA2467321A1 (en) 2004-05-14 2005-11-14 Paul J. Santerre Polymeric coupling agents and pharmaceutically-active polymers made therefrom
WO2006022944A2 (en) 2004-07-21 2006-03-02 Dana-Farber Cancer Institute, Inc. Lentiviral vectors and uses thereof
UA90864C2 (en) * 2004-09-09 2010-06-10 Ромарк Лебораториз, Л.К. Halogenated benzamide derivatives
CA2636527C (en) 2006-01-09 2016-05-17 Romark Laboratories, L.C. Viral hepatitis treatment
BRPI0815057B8 (pt) 2007-08-03 2021-05-25 Romark Laboratories Lc composto, composição farmacêutica, e, uso de um composto
PE20121118A1 (es) 2009-05-12 2012-09-05 Romark Lab Lc Compuestos de haloalquil heteroaril benzamida
EP2445349B1 (en) 2009-06-26 2022-02-09 Romark Laboratories, L.C. Compounds and methods for treating influenza
GB2487166B (en) 2009-10-22 2018-07-25 Borody Thomas J Composition comprising a fluoroquinolone and an imidazole for use in the treatment of Blastocystis hominis infection
CN104094927B (zh) * 2013-04-02 2016-06-01 兴邦（武汉）生物科技有限公司 一种处理植物的助剂组合物
TW201630606A (zh) * 2015-01-21 2016-09-01 諾華公司 包含局部藥物之蓋崙（ｇａｌｅｎｉｃ）調配物
US11612567B2 (en) 2018-02-02 2023-03-28 Ripple Therapeutics Corporation Ocular inserts comprising a covalently linked steroid dimer
EP4146664A2 (en) 2020-05-01 2023-03-15 Ripple Therapeutics Corporation Heterodimer compositions and methods for the treatment of ocular disorders
US20240285589A1 (en) * 2021-05-28 2024-08-29 Theodore Henderson Treatment using an antiviral compound and nitazoxanide

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1306603A (fr) * 1958-08-14 1962-10-19 Innothera Lab Sa Dérivés thiazoliques et leur procédé de préparation
FR716M (da) * 1960-08-05 1961-08-07
GB1437800A (en) * 1973-08-08 1976-06-03 Phavic Sprl Derivatives of 2-benzamido-5-nitro-thiazoles
FR2435905A1 (fr) * 1978-09-13 1980-04-11 Anvar Nouveaux agents molluscicides derives du benzamido-2 nitro-5 thiazole
US4315018A (en) * 1978-12-07 1982-02-09 Rossignol Jean F Specific parasiticidal use of 2-benzamido-5-nitro-thiazole derivatives
US4447414A (en) * 1982-12-21 1984-05-08 Cutter Laboratories, Inc. Carnivore anthelmintics

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY V. 12, N. 3, PP.353-6 (SEP 1977) *

Also Published As

Publication number Publication date
FI120258B (fi) 2009-08-31
FI964031A (fi) 1996-10-08
KR100348440B1 (ko) 2002-11-29
HU9602798D0 (en) 1996-12-30
FI964031A0 (fi) 1996-10-08
JPH09511997A (ja) 1997-12-02
PT755386E (pt) 2002-11-29
CA2187110C (en) 2002-03-19
BG62932B1 (bg) 2000-11-30
AP9600866A0 (en) 1996-10-31
ES2161201T1 (es) 2001-12-01
CN1145621A (zh) 1997-03-19
DE69526936T2 (de) 2003-02-20
KR100373081B1 (ko) 2003-02-25
BG100884A (en) 1997-07-31
ES2161201T3 (es) 2002-12-01
JP3224395B2 (ja) 2001-10-29
AU689582B2 (en) 1998-04-02
PL186504B1 (pl) 2004-01-30
CZ287002B6 (en) 2000-08-16
RU2140915C1 (ru) 1999-11-10
CN1072654C (zh) 2001-10-10
CZ295996A3 (en) 1997-03-12
AU2344095A (en) 1995-11-10
OA10463A (en) 2002-04-03
EP0755386A1 (en) 1997-01-29
NZ284800A (en) 1998-02-26
SI0755386T1 (en) 2002-10-31
EP0755386B1 (en) 2002-06-05
DK0755386T3 (da) 2002-08-26
DE69526936D1 (de) 2002-07-11
WO1995028393A1 (en) 1995-10-26
SK130796A3 (en) 1997-06-04
ATE218557T1 (de) 2002-06-15
SK281949B6 (sk) 2001-09-11
BR9507371A (pt) 1997-09-23
PL316757A1 (en) 1997-02-03
HUT77404A (hu) 1998-04-28
CA2187110A1 (en) 1995-10-26

Similar Documents

Publication Publication Date Title
AP645A (en) Benzamine derivative, compositions containing said derivative and use thereof.
MXPA96004483A (en) Derivatives of benzamide, compositions that contain such derivative and use of the mis
AU2002244638B2 (en) Fumaric acid derivatives as NF-kappaB inhibitors
KR100412298B1 (ko) 콜로이드이산화규소를함유하는발라시클로비르정제
US6020353A (en) 2-(hydroxy)-N-(5-nitro-2-thiazolyl) benzamide
US5387598A (en) Composition and galenic formulation suitable for combatting affections of the lower abdomen
WO2001045712A1 (de) Arzneimittelkombinationen gegen virale erkrankungen
DE68906735T2 (de) Pharmazeutische zubereitung zur behandlung von viruskrankheiten mit leber-extrakt.
AU740022B2 (en) Pharmaceutical compositions of tizoxanide and nitazoxanide
US20150158825A1 (en) Method for treating liver diseases of various origins
SK50696A3 (en) Flavin and its derivatives as anti-viral agents
RO118293B1 (ro) Derivat de benzamida, compozitii continand acest derivat si utilizarea acestuia
DE3707652A1 (de) Verwendung von benzo(de)isochinolin-1,3-dionen zur herstellung von arzneimitteln
MXPA00010855A (es) Uso de derivados de benzamida como agentes parasitarios, antibacterianos, antivirales y antifungicos
JPH09508150A (ja) Ｂ型肝炎の予防または治療のためのチオケテン誘導体の用途
CZ2020210A3 (cs) Léková forma s obsahem chininu a jeho solí pro perorální aplikaci
CZ329091A3 (cs) Léková forma s obsahem chininu nebo jeho solí pro perorální aplikaci
Nwankwo et al. Liver and Kidney Function Tests and Histological Study on Malaria Parasite Infected Mice Administered with Seed Extract of Picralima nitida
DE10012259A1 (de) Arzneimittelkombination gegen virale Erkrankungen
JPH02149524A (ja) ひと免疫不全ウイルス性疾患処置剤
AU5785901A (en) Pharmaceutical compositions of tizoxanide and nitazoxanide